{"bill": {"#text": " \n", "form": {"current-chamber": {"#tail": " \n", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n", "congress": {"#tail": "\n", "#text": "113th CONGRESS"}, "#tail": " \n", "legis-num": {"#tail": " \n", "#text": "H. R. 5614"}, "official-title": {"#tail": " \n", "#text": "To reauthorize the United States Anti-Doping Agency, and for other purposes."}, "session": {"#tail": "\n", "#text": "2d Session"}, "distribution-code": {"#tail": " \n", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": " \n", "@date": "20140918", "#text": "September 18, 2014"}, "#tail": " \n", "action-desc": {"#tail": "\n", "#text": "\n        ", "committee-name": {"#tail": "\n      ", "@committee-id": "HIF00", "#text": "Committee on Energy and Commerce"}, "sponsor": {"#tail": " (for himself and ", "#text": "Mr. Johnson of Ohio", "@name-id": "J000292"}, "cosponsor": {"#tail": ") introduced the following bill; which was referred to the ", "#text": "Mr. Tonko", "@name-id": "T000469"}}, "#text": " \n"}, "legis-type": {"#tail": " \n", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "HCFAA1DFC65D64C399898D9448B95B3C7", "@public-private": "public", "legis-body": {"#tail": " \n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": " \n", "text": {"#tail": "\n    ", "quote": {"short-title": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "act", "#text": "United States Anti-Doping Agency Reauthorization Act", "@value": "United States Anti-Doping Agency Reauthorization Act", "@proposed": "true"}, "#text": "\n            "}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "H6D2ECFB41E2546E8A255124C1BE77AC6"}, {"#tail": " \n", "text": {"#tail": " \n", "#text": "\n        ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 701 of title VII of the Office of National Drug Control Policy Reauthorization Act of 2006", "@value": "Office of National Drug Control Policy Reauthorization Act of 2006/s:701"}, "@entity-type": "law-citation", "#text": "\n          ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n        ", "@entity-type": "uscode", "#text": "21 U.S.C. 2001", "@value": "usc/21/2001"}, "@parsable-cite": "usc/21/2001", "#text": "\n          ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n      ", "#text": "Prohibit performance-enhancing methods"}, "paragraph": [{"#tail": " \n", "text": {"#tail": "\n      ", "#text": "in subsection (a), by striking paragraph (4); and"}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "@id": "H10999D1EDFA74080864AB1EDE3CDD082", "#text": "\n        "}, {"#tail": "\n    ", "text": {"#tail": " \n", "#text": "in subsection (b)\u2014"}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "#text": "\n        ", "@id": "H67C6206BDADC4A3BAE24DDE4F9F49A29", "subparagraph": [{"#tail": " \n", "text": {"#tail": "\n        ", "quote": [{"#tail": " after ", "#text": "and be recognized worldwide as the independent national anti-doping organization for the United States"}, {"#tail": ";", "#text": "Committee"}], "#text": "in paragraph (1), by inserting "}, "enum": {"#tail": "\n          ", "#text": "(A)"}, "@id": "H090E611B634245EEBA530BDB57197938", "#text": "\n          "}, {"#tail": " \n", "text": {"#tail": "\n        ", "quote": [{"#tail": " and inserting ", "#text": ", or performance-enhancing genetic modifications accomplished through gene-doping"}, {"#tail": ";", "#text": "or prohibited performance-enhancing methods adopted by the Agency"}], "#text": "in paragraph (2), by striking "}, "enum": {"#tail": "\n          ", "#text": "(B)"}, "@id": "HE2E0AE5E80894543A2DD2AF2754211DD", "#text": "\n          "}, {"#tail": " \n", "text": {"#tail": "\n        ", "quote": [{"#tail": " and inserting ", "#text": ", or performance-enhancing genetic modifications accomplished through gene-doping"}, {"#tail": ";", "#text": "or prohibited performance-enhancing methods adopted by the Agency"}], "#text": "in paragraph (3), by striking "}, "enum": {"#tail": "\n          ", "#text": "(C)"}, "@id": "H0488EFA4D0954F40859407CA199DE96D", "#text": "\n          "}, {"#tail": " \n", "text": {"#tail": "\n        ", "quote": [{"#tail": " and inserting ", "#text": "and the prevention of use of performance-enhancing drugs, or performance-enhancing genetic modifications accomplished through gene-doping by United States amateur athletes; and"}, {"#tail": "; and", "#text": ", and the prevention of use by United States amateur athletes of performance-enhancing drugs or prohibited performance-enhancing methods adopted by the Agency."}], "#text": "in paragraph (4), by striking "}, "enum": {"#tail": "\n          ", "#text": "(D)"}, "@id": "H3CAE1FC508A04E8CA9963DD836277931", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n        ", "#text": "by striking paragraph (5)."}, "enum": {"#tail": "\n          ", "#text": "(E)"}, "@id": "H1B41CCED38AC4DB9A921648F0538DA2F", "#text": "\n          "}]}], "#text": "\n      ", "@id": "H683A3363EBCF4A80AD977F51916C2835"}, {"#tail": " \n", "text": {"#tail": " \n", "#text": "\n        ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended to read as follows:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 703 of title VII of the Office of National Drug Control Policy Reauthorization Act of 2006", "@value": "Office of National Drug Control Policy Reauthorization Act of 2006/s:703"}, "@entity-type": "law-citation", "#text": "\n          ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n        ", "@entity-type": "uscode", "#text": "21 U.S.C. 2003", "@value": "usc/21/2003"}, "@parsable-cite": "usc/21/2003", "#text": "\n          ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": "\n      ", "#text": "Authorization of appropriations"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n      ", "#text": "."}, "#tail": "\n    ", "section": {"#tail": "\n        ", "text": {"#tail": " \n", "#text": "There are authorized to be appropriated to the United States Anti-Doping Agency\u2014", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n          ", "#text": "703."}, "header": {"#tail": "\n          ", "#text": "Authorization of appropriations"}, "paragraph": [{"#tail": " \n", "#text": "\n            ", "@id": "H686C52D08F484C31B4FB54DFBB272188", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n          ", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": ";", "#text": "for fiscal year 2014, $11,300,000", "@amount": "11300000", "@year": "2014"}, "#text": "\n                "}, "@entity-type": "auth-auth-approp", "enum": {"#tail": "\n            ", "#text": "(1)"}, "#text": "\n              "}}, {"#tail": " \n", "#text": "\n            ", "@id": "H0EE15AA235B544E9A18D6F471D59F942", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n          ", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": ";", "#text": "for fiscal year 2015, $11,700,000", "@amount": "11700000", "@year": "2015"}, "#text": "\n                "}, "@entity-type": "auth-auth-approp", "enum": {"#tail": "\n            ", "#text": "(2)"}, "#text": "\n              "}}, {"#tail": " \n", "#text": "\n            ", "@id": "H5D45AF89D0EF4E2F8ACD5C195CFE4551", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n          ", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": ";", "#text": "for fiscal year 2016, $12,300,000", "@amount": "12300000", "@year": "2016"}, "#text": "\n                "}, "@entity-type": "auth-auth-approp", "enum": {"#tail": "\n            ", "#text": "(3)"}, "#text": "\n              "}}, {"#tail": " \n", "#text": "\n            ", "@id": "HF53B72AAF1164791B0561DE825D21913", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n          ", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": ";", "#text": "for fiscal year 2017, $12,900,000", "@amount": "12900000", "@year": "2017"}, "#text": "\n                "}, "@entity-type": "auth-auth-approp", "enum": {"#tail": "\n            ", "#text": "(4)"}, "#text": "\n              "}}, {"#tail": " \n", "#text": "\n            ", "@id": "HA9820F021AE34B9DA5B3A7C36CA005CE", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n          ", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": ";", "#text": "for fiscal year 2018, $13,500,000", "@amount": "13500000", "@year": "2018"}, "#text": "\n                "}, "@entity-type": "auth-auth-approp", "enum": {"#tail": "\n            ", "#text": "(5)"}, "#text": "\n              "}}, {"#tail": " \n", "#text": "\n            ", "@id": "H5040E47945B544B9B53C110CD9BF6D54", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n          ", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": "; and", "#text": "for fiscal year 2019, $14,100,000", "@amount": "14100000", "@year": "2019"}, "#text": "\n                "}, "@entity-type": "auth-auth-approp", "enum": {"#tail": "\n            ", "#text": "(6)"}, "#text": "\n              "}}, {"#tail": "\n        ", "#text": "\n            ", "@id": "H5773CD1FE27943DE885874D618390C15", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n          ", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": ".", "#text": "for fiscal year 2020, $14,800,000", "@amount": "14800000", "@year": "2020"}, "#text": "\n                "}, "@entity-type": "auth-auth-approp", "enum": {"#tail": "\n            ", "#text": "(7)"}, "#text": "\n              "}}], "#text": "\n          ", "@id": "H76C5EECA4BEA496DBAACB6EB1BA597D3"}, "#text": " \n", "@id": "HA9FB0FFB16FA4B97AC6BA06CA034D4FC"}, "#text": "\n      ", "@id": "H0B75C1BC6CC24FCB80A7A20CC93BD696"}], "#text": " \n", "@id": "H3DE0146F04A7491BBE5E85E6E169B6E2"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2014-09-18"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 HR 5614 IH: United States Anti-Doping Agency Reauthorization Act"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. House of Representatives"}, "#text": "\n"}, "#text": "\n"}}}